Springer Nature

Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer

Posted on 2020-11-12 - 04:44
Abstract One unmet challenge in lung cancer diagnosis is to accurately differentiate lung cancer from other lung diseases with similar clinical symptoms and radiological features, such as pulmonary tuberculosis (TB). To identify reliable biomarkers for lung cancer screening, we leverage the recently discovered non-canonical small non-coding RNAs (i.e., tRNA-derived small RNAs [tsRNAs], rRNA-derived small RNAs [rsRNAs], and YRNA-derived small RNAs [ysRNAs]) in human peripheral blood mononuclear cells and develop a molecular signature composed of distinct ts/rs/ysRNAs (TRY-RNA). Our TRY-RNA signature precisely discriminates between control, lung cancer, and pulmonary TB subjects in both the discovery and validation cohorts and outperforms microRNA-based biomarkers, which bears the diagnostic potential for lung cancer screening.


3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
AAPG Bulletin
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Select your citation style and then place your mouse over the citation text to select it.



Usage metrics

Molecular Cancer


Wanjun Gu
Junchao Shi
Hui Liu
Xudong Zhang
Jin J. Zhou
Musheng Li
Dandan Zhou
Rui Li
Jingzhu Lv
Guoxia Wen
Shanshan Zhu
Ting Qi
Wei Li
Xiaojing Wang
Zhaohua Wang
Hua Zhu
Changcheng Zhou
Kenneth S. Knox
Ting Wang
Qi Chen
need help?